These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16128714)

  • 1. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98.
    Humphreys K; Weingardt KR; Horst D; Joshi AA; Finney JW
    Addiction; 2005 Sep; 100(9):1249-57. PubMed ID: 16128714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the interpretation of criteria for clinical trial eligibility: a survey of oncology investigators.
    Weijer C; Freedman B; Shapiro S; Fuks A; Skrutkowska M; Sigurjonsdottir M
    Clin Invest Med; 1998 Feb; 21(1):17-26. PubMed ID: 9512881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations on use of biomarkers in alcoholism treatment trials.
    Allen JP; Litten RZ
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1667-70. PubMed ID: 14574239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage.
    Jaffe J; AlKhawam L; Du H; Tobin K; O'Leary J; Pollock G; Batjer HH; Awad IA
    Neurosurgery; 2009 Mar; 64(3):436-45; discussion 445-6. PubMed ID: 19240605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials.
    Yuen SY; Pope JE
    Rheumatology (Oxford); 2008 Sep; 47(9):1367-72. PubMed ID: 18577549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical dependency patients with cooccurring psychiatric diagnoses: service patterns and 1-year outcomes.
    Chi FW; Satre DD; Weisner C
    Alcohol Clin Exp Res; 2006 May; 30(5):851-9. PubMed ID: 16634854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of enrolment eligibility criteria in alcohol treatment outcome research: generalisability and potential bias in 1- and 6-year outcomes.
    Storbjörk J
    Drug Alcohol Rev; 2014 Nov; 33(6):604-11. PubMed ID: 25303086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research.
    Humphreys K; Harris AH; Weingardt KR
    J Stud Alcohol Drugs; 2008 Sep; 69(5):757-64. PubMed ID: 18781251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What role does measuring medication compliance play in evaluating the efficacy of naltrexone?
    Baros AM; Latham PK; Moak DH; Voronin K; Anton RF
    Alcohol Clin Exp Res; 2007 Apr; 31(4):596-603. PubMed ID: 17374038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bias in uncontrolled therapeutic trials in rheumatology due to selection of populations with extreme characteristics.
    Ioannidis JP; Karassa FB
    J Rheumatol; 2001 Aug; 28(8):1881-7. PubMed ID: 11508595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of exclusion criteria in antidepressant clinical trials: a replication study.
    Zetin M; Hoepner CT
    J Clin Psychopharmacol; 2007 Jun; 27(3):295-301. PubMed ID: 17502778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review.
    Bradizza CM; Stasiewicz PR; Paas ND
    Clin Psychol Rev; 2006 Mar; 26(2):162-78. PubMed ID: 16406196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the role of health services research as a tool to reduce the public health burden of alcohol use disorders.
    Delany PJ; Shields JJ; Willenbring ML; Huebner RB
    Subst Use Misuse; 2008; 43(12-13):1729-46. PubMed ID: 19016162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcoholism treatment matching research: methodological and clinical issues.
    Donovan DM; Mattson ME
    J Stud Alcohol Suppl; 1994 Dec; 12():5-14. PubMed ID: 7722998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies.
    Humphreys K; Weisner C
    Am J Psychiatry; 2000 Apr; 157(4):588-94. PubMed ID: 10739418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting lifetime alcohol problems in individuals referred for liver transplantation for nonalcoholic liver failure.
    Day E; Best D; Sweeting R; Russell R; Webb K; Georgiou G; Neuberger J
    Liver Transpl; 2008 Nov; 14(11):1609-13. PubMed ID: 18975295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance with aftercare treatment, including disulfiram, and effect on outcome in alcohol-dependent patients.
    Neto D; Lambaz R; Tavares JE
    Alcohol Alcohol; 2007; 42(6):604-9. PubMed ID: 17878216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.